Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 20, Issue 46, 2014, Pages 17483-17490

  Ni, Jia Yan ^a   Sun, Hong Liang ^a   Chen, Yao Ting ^a   Luo, Jiang Hong ^a   Chen, Dong ^a   Jiang, Xiong Ying ^a   Xu, Lin Feng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Microwave ablation; Prognosis; Survival; Transarterial chemoembolization

Indexed keywords

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; ASCITES; BLEEDING; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD PUGH SCORE; DRUG USE; FEMALE; FEVER; FOLLOW UP; HUMAN; JAUNDICE; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MICROWAVE THERAPY; NAUSEA; OVERALL SURVIVAL; PALLIATIVE THERAPY; PORTAL VEIN; RISK FACTOR; SCORING SYSTEM; SURVIVAL RATE; TRANSARTERIAL CHEMOEMBOLIZATION; TUMOR THROMBUS; TUMOR VOLUME; VOMITING; ABLATION THERAPY; ADJUVANT CHEMOTHERAPY; ADVERSE EFFECTS; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; CHI SQUARE DISTRIBUTION; COMPLICATION; KAPLAN MEIER METHOD; LIVER NEOPLASMS; MICROWAVE RADIATION; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURGERY; THERAPEUTIC USE; TIME; TREATMENT OUTCOME; VENOUS THROMBOSIS; YOUNG ADULT;

ABLATION TECHNIQUES; ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MICROWAVES; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PORTAL VEIN; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84918502150     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i46.17483     Document Type: Article

References (30)

1. Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010; 15 Suppl 4: 5-13 [PMID: 21115576 DOI: 10.1634/theoncologist.2010-S4-0 5]
2. Ferenci P, Fried M, Labrecque D, Bruix J, Sherman M, Omata M, Heathcote J, Piratsivuth T, Kew M, Otegbayo JA, Zheng SS, Sarin S, Hamid S, Modawi SB, Fleig W, Fedail S, Thomson A, Khan A, Malfertheiner P, Lau G, Carillo FJ, Krabshuis J, Le Mair A. World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective. J Gastrointestin Liver Dis 2010; 19: 311-317 [PMID: 20922197]
3. Padhya KT, Marrero JA, Singal AG. Recent advances in the treatment of hepatocellular carcinoma. Curr Opin Gastroenterol 2013; 29: 285-292 [PMID: 23507917 DOI: 10.1097/MOG.0b013e32835ff1cf]
4. Hennedige T, Venkatesh SK. Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring. Cancer Imaging 2013; 12: 530-547 [PMID: 23400006 DOI: 10.1102/1470-7330.2012.0044]
5. Su JS, Chen YT, Wang RC, Wu CY, Lee SW, Lee TY. Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review. World J Gastroenterol 2013; 19: 321-327 [PMID: 23372352 DOI: 10.3748/wjg.v19.i3.321]
6. McCurdy HM. Improving outcomes for patients receiving transarterial chemoembolization for hepatocellular carcinoma. Gastroenterol Nurs 2013; 36: 114-120 [PMID: 23549214 DOI: 10.1097/SGA.0b013e318288c8be]
7. Kishi Y, Saiura A, Yamamoto J, Koga R, Seki M, Morimura R, Yoshioka R, Kokudo N, Yamaguchi T. Preoperative transarterial chemoembolization for hepatocellular carcinoma. Hepatogastroenterology 2012; 59: 2295-2299 [PMID: 23435144 DOI: 10.5754/hge10730]
8. Marelli L, Shusang V, Buscombe JR, Cholongitas E, Stigliano R, Davies N, Tibballs J, Patch D, Meyer T, Burroughs AK. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer. J Nucl Med 2009; 50: 871-877 [PMID: 19443599 DOI: 10.2967/jnumed.108.060558]
9. Kim KM, Kim JH, Park IS, Ko GY, Yoon HK, Sung KB, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion. J Gastroenterol Hepatol 2009; 24: 806-814 [PMID: 19207681 DOI: 10.1111/j.1440-1746.2008.05728.x]
10. Poon RT, Ngan H, Lo CM, Liu CL, Fan ST, Wong J. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol 2000; 73: 109-114 [PMID: 10694648]
11. Tombesi P, Di Vece F, Sartori S. Resection vs thermal ablation of small hepatocellular carcinoma: What's the first choice? World J Radiol 2013; 5: 1-4 [PMID: 23493926 DOI: 10.4329/wjr.v5.i1.1]
12. Minami Y, Kudo M. Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma. World J Gastroenterol 2011; 17: 4952-4959 [PMID: 22174544 DOI: 10.3748/wjg.v17.i45.4952]
13. Liu C, Liang P, Liu F, Wang Y, Li X, Han Z, Liu C. MWA combined with TACE as a combined therapy for unresectable large-sized hepotocellular carcinoma. Int J Hyperthermia 2011; 27: 654-662 [PMID: 21966941 DOI: 10.3109/02656736.20 11.605099]
14. Xu LF, Sun HL, Chen YT, Ni JY, Chen D, Luo JH, Zhou JX, Hu RM, Tan QY. Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy. J Gastroenterol Hepatol 2013; 28: 456-463 [PMID: 23216261 DOI: 10.1111/jgh.12088]
15. Fong ZV, Palazzo F, Needleman L, Brown DB, Eschelman DJ, Chojnacki KA, Yeo CJ, Rosato EL. Combined hepatic arterial embolization and hepatic ablation for unresectable colorectal metastases to the liver. Am Surg 2012; 78: 1243-1248 [PMID: 23089443]
16. Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, Kim PN. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone. Eur J Radiol 2012; 81: e189-e193 [PMID: 21353417 DOI: 10.1016/j.ejrad.2011.01.122]
17. Yang W, Chen MH, Wang MQ, Cui M, Gao W, Wu W, Wu JY, Dai Y, Yan K. Combination therapy of radiofrequency ablation and transarterial chemoembolization in recurrent hepatocellular carcinoma after hepatectomy compared with single treatment. Hepatol Res 2009; 39: 231-240 [PMID: 19054154 DOI: 10.1111/j.1872-034X.2008.00451.x]
18. Shen SQ, Xiang JJ, Xiong CL, Wu SM, Zhu SS. Intraoperative radiofrequency thermal ablation combined with portal vein infusion chemotherapy and transarterial chemoembolization for unresectable HCC. Hepatogastroenterology 2005; 52:1403-1407 [PMID: 16201083]
19. Kawaguchi T, Ohkawa K, Imanaka K, Tamai C, Kawada N, Ikezawa K, Uehara H, Itou Y, Nakanishi K, Katayama K. Lipiodol accumulation and transarterial chemoembolization efficacy for HCC patients. Hepatogastroenterology 2012; 59: 219-223 [PMID: 22260832 DOI: 10.5754/hge11258]
20. Burrel M, Reig M, Forner A, Barrufet M, de Lope CR, Tremosini S, Ayuso C, Llovet JM, Real MI, Bruix J. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design. J Hepatol 2012; 56: 1330-1335 [PMID: 22314428 DOI: 10.1016/j.jhep.2012.01.008]
21. Liang P, Dong B, Yu X, Yu D, Wang Y, Feng L, Xiao Q. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005; 235: 299-307 [PMID: 15731369]
22. Peng ZW, Zhang YJ, Liang HH, Lin XJ, Guo RP, Chen MS. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Radiology 2012; 262: 689-700 [PMID: 22157201 DOI: 10.1148/radiol.11110637]
23. Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022 [PMID: 21374666 DOI: 10.1002/hep.24199]
24. Minagawa M, Makuuchi M. Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol 2006; 12: 7561-7567 [PMID: 17171782]
25. Aldrighetti L, Pulitanò C, Catena M, Arru M, Guzzetti E, Halliday J, Ferla G. Liver resection with portal vein thrombectomy for hepatocellular carcinoma with vascular invasion. Ann Surg Oncol 2009; 16: 1254 [PMID: 19277788 DOI: 10.1245/s10434-009-0383-y]
26. Nie L, Luo XF, Li X. Gastrointestinal bleeding caused by extrahepatic arterioportal fistula associated with portal vein thrombosis. World J Gastroenterol 2012; 18: 6501-6503 [PMID: 23197898 DOI: 10.3748/wjg.v18.i44.6501]
27. Ngan H, Peh WC. Arteriovenous shunting in hepatocellular carcinoma: its prevalence and clinical significance. Clin Radiol 1997; 52: 36-40 [PMID: 9022578]
28. Genco C, Cabibbo G, Maida M, Brancatelli G, Galia M, Alessi N, Butera G, Genova C, Romano P, Raineri M, Giarratano A, Midiri M, Cammà C. Treatment of hepatocellular carcinoma: present and future. Expert Rev Anticancer Ther 2013; 13: 469-479 [PMID: 23560841 DOI: 10.1586/era.13.21]
29. D'Angelo S, Secondulfo M, De Cristofano R, Sorrentino P. Selection and management of hepatocellular carcinoma patients with sorafenib: recommendations and opinions from an Italian liver unit. Future Oncol 2013; 9: 485-491 [PMID: 23560372 DOI: 10.2217/fon.12.208]
30. Kim MS, Jin YJ, Lee JW, Lee JI, Kim YS, Lee SY, Chae MH. Complete remission of advanced hepatocellular carcinoma by sorafenib: A case report. World J Gastrointest Oncol 2013; 5: 38-42 [PMID: 23556056 DOI: 10.4251/wjgo.v5.i2.38]